{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:11:25Z","timestamp":1775477485213,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tcm.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:30:32Z","timestamp":1759012232000},"page":"134-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dilated cardiomyopathy in primary aldosteronism: A state-of-the-art of mechanistic insights, therapeutic strategies, and future perspectives"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7375-555X","authenticated-orcid":false,"given":"Luigi","family":"Marzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Zoccatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Friso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.tcm.2025.09.008_bib0001","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.tcm.2025.09.008_bib0002","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.09.008_bib0003","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2019.06.055","article-title":"Primary aldosteronism-associated cardiomyopathy: clinical-pathologic impact of aldosterone normalization","volume":"292","author":"Frustaci","year":"2019","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.tcm.2025.09.008_bib0004","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0031-1291318","article-title":"Aldosterone and the heart: from basic research to clinical evidence","volume":"44","author":"Catena","year":"2012","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0895-7061(02)03199-0","article-title":"Aldosterone-induced cardiac damage: focus on blood pressure independent effects","volume":"16","author":"Schmidt","year":"2003","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0007","first-page":"334","article-title":"Dilated cardiomyopathy and aldosteronoma: a causal link?","volume":"7","author":"Zhang","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.tcm.2025.09.008_bib0008","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3348\/kjr.2020.1291","article-title":"Left ventricular remodeling in patients with primary aldosteronism: a prospective cardiac magnetic resonance imaging study","volume":"22","author":"Wu","year":"2021","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.tcm.2025.09.008_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.916744","article-title":"Treatment of primary aldosteronism and reversal of Renin suppression improves left ventricular systolic function","volume":"13","author":"Puar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.tcm.2025.09.008_bib0010","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/HJH.0b013e3283550f93","article-title":"Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism","volume":"30","author":"Lin","year":"2012","journal-title":"J Hypertens"},{"issue":"8","key":"10.1016\/j.tcm.2025.09.008_bib0011","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1161\/HYPERTENSIONAHA.125.25104","article-title":"Adrenalectomy versus medical therapy in primary aldosteronism: a meta-analysis of long-term cardiac remodeling and function: medical versus Adrenalectomy treatment compared in hyperaldosteronism (MATCH) study","volume":"82","author":"Marzano","year":"2025","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.tcm.2025.09.008_bib0012","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","article-title":"Clinical management of primary aldosteronism: an update","volume":"81","author":"Rossi","year":"2024","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0013","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrneph.2009.228","article-title":"Aldosterone 'escape' vs 'breakthrough","volume":"6","author":"Schrier","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"37","key":"10.1016\/j.tcm.2025.09.008_bib0014","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2025.09.008_bib0015","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2025.09.008_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132571","article-title":"The \"Padua classification\" of cardiomyopathies: combining pathobiological basis and morpho-functional remodeling","volume":"418","author":"Corrado","year":"2025","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.tcm.2025.09.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030142","article-title":"Adverse effects of aldosterone: beyond blood pressure","volume":"13","author":"Brown","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.tcm.2025.09.008_bib0020","article-title":"Multimodality imaging in aldosterone-induced cardiomyopathy: early detection and prognostic implications","volume":"15","author":"Zoccatelli","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0021","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"38","key":"10.1016\/j.tcm.2025.09.008_bib0022","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.tcm.2025.09.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102791","article-title":"Global and regional prevalence and cardiovascular risk of primary aldosteronism: a systematic review and meta-analysis","volume":"49","author":"Huang","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2025.09.008_bib0024","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.tcm.2025.09.008_bib0025","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/HYPERTENSIONAHA.124.22884","article-title":"Comparing ARR versus suppressed PRA as screening tests for primary aldosteronism","volume":"81","author":"Marcelli","year":"2024","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.tcm.2025.09.008_bib0026","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0027","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-22-0249","article-title":"Mineralocorticoid receptor signalling in primary aldosteronism","volume":"259","author":"Yang","year":"2023","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0028","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41371-020-00426-y","article-title":"Left ventricular remodeling and dysfunction in primary aldosteronism","volume":"35","author":"Tsai","year":"2021","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0029","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41569-024-01074-2","article-title":"Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine","volume":"22","author":"Gigli","year":"2025","journal-title":"Nat Rev Cardiol"},{"issue":"10406","key":"10.1016\/j.tcm.2025.09.008_bib0032","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tcm.2025.09.008_bib0033","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/1470320314549220","article-title":"Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism","volume":"16","author":"Indra","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"11","key":"10.1016\/j.tcm.2025.09.008_bib0034","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/jch.14912","article-title":"Primary aldosteronism influences cardiac structure, function, and disease risk: evidence from mendelian randomization analysis","volume":"26","author":"Shen","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.tcm.2025.09.008_bib0035","article-title":"CMR-verified myocardial fibrosis is associated with subclinical diastolic dysfunction in primary aldosteronism patients","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.tcm.2025.09.008_bib0036","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5603\/AH.a2021.0006","article-title":"Primary aldosteronism and coronary-pulmonary artery fistula: coincidence or causal link? A case report and literature review","volume":"25","author":"Marzano","year":"2021","journal-title":"Arterial Hypertension"},{"issue":"23","key":"10.1016\/j.tcm.2025.09.008_bib0037","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tcm.2025.09.008_bib0038","first-page":"2689","article-title":"Curable congestive heart failure in patients with primary aldosteronism: two cases reports","volume":"14","author":"Chen","year":"2022","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjhyper.2005.05.013","article-title":"Role of aldosterone in left ventricular hypertrophy in hypertension","volume":"19","author":"Matsumura","year":"2006","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1530\/EC-20-0504","article-title":"Aldosterone-induced cardiac damage in primary aldosteronism depends on its subtypes","volume":"10","author":"Higuchi","year":"2021","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0041","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1007708025567","article-title":"Echocardiographic findings of the heart resembling dilated cardiomyopathy during hypokalemic myopathy due to licorice-induced pseudoaldosteronism","volume":"12","author":"Hasegawa","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.tcm.2025.09.008_bib0042","first-page":"76","article-title":"Dilated cardiomyopathy with electrocardiographic changes and coronary-pulmonary fistula: an uncommon presentation of primary aldosteronism In the Covid-19 era","author":"Marzano","year":"2020","journal-title":"Hypertension"},{"issue":"15","key":"10.1016\/j.tcm.2025.09.008_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.034180","article-title":"Primary aldosteronism and risk of cardiovascular outcomes: genome-wide association and mendelian randomization study","volume":"13","author":"Inoue","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.tcm.2025.09.008_bib0044","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/HYPERTENSIONAHA.123.21895","article-title":"Mortality in patients with primary aldosteronism: a Swedish nationwide study","volume":"80","author":"Gkaniatsa","year":"2023","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ehjqcco\/qcae109","article-title":"Diagnosis and management of dilated cardiomyopathy: a systematic review of clinical practice guidelines and recommendations","volume":"11","author":"Sorella","year":"2025","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0046","doi-asserted-by":"crossref","first-page":"F1178","DOI":"10.1152\/ajprenal.00386.2003","article-title":"Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet","volume":"286","author":"Wang","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0047","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0048","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/HYPERTENSIONAHA.107.092403","article-title":"Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension","volume":"50","author":"Lebrasseur","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0049","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1071-9164(03)00578-5","article-title":"Role of a selective aldosterone blocker in mice with chronic heart failure","volume":"10","author":"Wang","year":"2004","journal-title":"J Card Fail"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0050","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","article-title":"Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension","volume":"71","author":"Brilla","year":"1993","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2025.09.008_bib0051","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/08037051.2021.1904775","article-title":"Preclinical cardiac disease in women and men with primary aldosteronism","volume":"30","author":"Aune","year":"2021","journal-title":"Blood Press"},{"issue":"22","key":"10.1016\/j.tcm.2025.09.008_bib0052","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013263","article-title":"Left ventricular dysfunction in patients with primary aldosteronism: a propensity score-matching follow-up study with tissue doppler imaging","volume":"8","author":"Chang","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0053","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"issue":"15","key":"10.1016\/j.tcm.2025.09.008_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15151896","article-title":"Multimodality imaging in aldosterone-induced cardiomyopathy: early detection and prognostic implications","volume":"15","author":"Zoccatelli","year":"2025","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.tcm.2025.09.008_bib0055","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.echo.2014.07.006","article-title":"Assessment of left ventricular volumes with echocardiography and cardiac magnetic resonance imaging: real-life evaluation of standard versus new semiautomatic methods","volume":"27","author":"Aurich","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"10.1016\/j.tcm.2025.09.008_bib0056","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/ehjci\/jew042","article-title":"Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking","volume":"17","author":"Aurich","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.tcm.2025.09.008_bib0057","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ehjci\/jev227","article-title":"Direct comparison of cardiac magnetic resonance feature tracking and 2D\/3D echocardiography speckle tracking for evaluation of global left ventricular strain","volume":"17","author":"Obokata","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0058","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1038\/s41598-024-54971-4","article-title":"Association of the trajectory of plasma aldosterone concentration with the risk of cardiovascular disease in patients with hypertension: a cohort study","volume":"14","author":"Cai","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.tcm.2025.09.008_bib0059","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","article-title":"Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study","volume":"31","author":"Tomaschitz","year":"2010","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.tcm.2025.09.008_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8071045","article-title":"Serum aldosterone is related to left ventricular geometry and function in young adults with never-treated primary hypertension","volume":"8","author":"Park","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.tcm.2025.09.008_bib0061","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trsl.2021.08.003","article-title":"Aldosterone suppresses cardiac mitochondria","volume":"239","author":"Hung","year":"2022","journal-title":"Transl Res"},{"key":"10.1016\/j.tcm.2025.09.008_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10877","article-title":"Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases","volume":"7","author":"Cannavo","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.tcm.2025.09.008_bib0063","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051119","article-title":"Aldosterone suppresses endothelial mitochondria through mineralocorticoid receptor\/mitochondrial reactive oxygen species pathway","volume":"10","author":"Peng","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0064","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11596-010-0362-3","article-title":"Aortic cell apoptosis in rat primary aldosteronism model","volume":"30","author":"Yan","year":"2010","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"9507","key":"10.1016\/j.tcm.2025.09.008_bib0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tcm.2025.09.008_bib0066","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCGENETICS.113.000115","article-title":"Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations","volume":"6","author":"Escoubet","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0067","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ajh\/hpy175","article-title":"Speckle-tracking echocardiographic layer-specific strain analysis on subclinical left ventricular dysfunction in patients with primary aldosteronism","volume":"32","author":"Wang","year":"2019","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.tcm.2025.09.008_bib0068","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jcmg.2020.06.026","article-title":"Aldosterone-related myocardial extracellular matrix expansion in hypertension in humans: a proof-of-concept study by Cardiac magnetic resonance","volume":"13","author":"Redheuil","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0069","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-5193(86)80064-9","article-title":"Comparative cardiac mechanics: laplace's Law","volume":"118","author":"Li","year":"1986","journal-title":"J Theor Biol"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0070","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/HJH.0000000000003696","article-title":"Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study","volume":"42","author":"Kokko","year":"2024","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0071","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/joim.13115","article-title":"Primary aldosteronism: higher volume load, cardiac output and arterial stiffness than in essential hypertension","volume":"289","author":"Choudhary","year":"2021","journal-title":"J Intern Med"},{"issue":"19","key":"10.1016\/j.tcm.2025.09.008_bib0072","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1113\/JP283632","article-title":"Cardiac efficiency and Starling's Law of the Heart","volume":"600","author":"Han","year":"2022","journal-title":"J Physiol"},{"issue":"15","key":"10.1016\/j.tcm.2025.09.008_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158099","article-title":"Epigenetic regulation of the renin-angiotensin-aldosterone system in hypertension","volume":"25","author":"Takeda","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.tcm.2025.09.008_bib0074","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.eprac.2024.04.007","article-title":"Cardiovascular outcomes of KCNJ5 mutated aldosterone-producing adenoma: a systematic review","volume":"30","author":"Kato","year":"2024","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.tcm.2025.09.008_bib0075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/HJH.0000000000002300","article-title":"Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based study","volume":"38","author":"Er","year":"2020","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0076","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/HYPERTENSIONAHA.115.05643","article-title":"Genetic and potential autoimmune triggers of primary aldosteronism","volume":"66","author":"Williams","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2025.09.008_bib0077","unstructured":"ClinicalTrials.gov. Evaluating the Prognostic Impact of Anti-\u03b21AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy. Study Start 2024-12-17. [updated NCT06741995. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06741995?cond=(primary%20aldosteronism%20seizures%20neurological%20abnormalities)%20OR%20(cac%20and)&rank=8&checkSpell=."},{"issue":"4","key":"10.1016\/j.tcm.2025.09.008_bib0078","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/HJH.0000000000002679","article-title":"Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies","volume":"39","author":"Cuspidi","year":"2021","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0079","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41440-023-01554-x","article-title":"Clinical and biochemical outcomes after adrenalectomy for primary aldosteronism in tertiary and quaternary referral centers: data from SOPRANO study","volume":"47","author":"Marzano","year":"2024","journal-title":"Hypertens Res"},{"issue":"9","key":"10.1016\/j.tcm.2025.09.008_bib0080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0081","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cen.14918","article-title":"Prognostic models to predict complete resolution of hypertension after adrenalectomy in primary aldosteronism: a systematic review and meta-analysis","volume":"99","author":"Marzano","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.tcm.2025.09.008_bib0082","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41371-022-00731-8","article-title":"Assessment of performance of stratum-specific likelihood ratios of the aldosteronoma resolution score for predicting hypertension cure after adrenalectomy for primary aldosteronism: a systematic review and meta-analysis","volume":"37","author":"Marzano","year":"2023","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0083","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/wjs.12030","article-title":"Letter to the editor: validation of the aldosteronoma resolution score as a predictive resolution score of hypertension after unilateral adrenalectomy for primary aldosteronism in a North-African population","volume":"48","author":"Marzano","year":"2024","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0084","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0029-1246185","article-title":"Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism","volume":"42","author":"Catena","year":"2010","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0085","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDctcs2100007","article-title":"Behind the scenes of TOPCAT - bending to inform","volume":"1","author":"Pfeffer","year":"2022","journal-title":"NEJM Evid"},{"issue":"10458","key":"10.1016\/j.tcm.2025.09.008_bib0086","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis","volume":"404","author":"Jhund","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0087","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajh\/hpu154","article-title":"Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies","volume":"28","author":"Marzano","year":"2015","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0088","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","article-title":"Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism","volume":"42","author":"Satoh","year":"2019","journal-title":"Hypertens Res"},{"issue":"11","key":"10.1016\/j.tcm.2025.09.008_bib0089","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1097\/JS9.0000000000002048","article-title":"Cardiovascular and all-cause mortality outcomes of adrenalectomy versus medical treatment in primary aldosteronism: an umbrella review","volume":"110","author":"Nayak","year":"2024","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41440-024-01946-7","article-title":"Evaluating the effects of adrenalectomy and mineralocorticoid receptor antagonist on cardiac remodeling and diastolic function in patients with aldosterone-producing adenoma","volume":"48","author":"Chang","year":"2025","journal-title":"Hypertens Res"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0091","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/HJH.0000000000003135","article-title":"Persistent cardiac organ damage in surgically and medically treated primary aldosteronism","volume":"40","author":"Aune","year":"2022","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.tcm.2025.09.008_bib0092","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCHEARTFAILURE.111.966366","article-title":"Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction","volume":"5","author":"Dunlay","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0093","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00392-019-01505-y","article-title":"Characteristics and outcomes of HFpEF with declining ejection fraction","volume":"109","author":"Park","year":"2020","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2025.09.008_bib0094","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2025.09.008_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102576","article-title":"Safety and efficacy of once-daily dexfadrostat phosphate in patients with primary aldosteronism: a randomised, parallel group, multicentre, phase 2 trial","volume":"71","author":"Mulatero","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.tcm.2025.09.008_bib0096","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/CIRCULATIONAHA.124.071452","article-title":"Efficacy and safety of finerenone in patients with primary aldosteronism: a pilot randomized controlled trial","volume":"151","author":"Hu","year":"2025","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tcm.2025.09.008_bib0097","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1161\/HYPERTENSIONAHA.124.23962","article-title":"Efficacy and safety of aldosterone synthase inhibitors for hypertension: a meta-analysis of randomized controlled trials and systematic review","volume":"82","author":"Marzano","year":"2025","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.tcm.2025.09.008_bib0098","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ejendo\/lvaf170","article-title":"Discordance and shortcomings of aldosterone suppression tests in primary aldosteronism","volume":"193","author":"Tsai","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.tcm.2025.09.008_bib0099","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41440-021-00725-y","article-title":"A non-invasive left ventricular pressure-strain loop study on myocardial work in primary aldosteronism","volume":"44","author":"Chen","year":"2021","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.tcm.2025.09.008_bib0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41371-023-00875-1","article-title":"Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society","volume":"38","author":"Faconti","year":"2024","journal-title":"J Hum Hypertens"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382500132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382500132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:30:51Z","timestamp":1775475051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017382500132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S105017382500132X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2025.09.008","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dilated cardiomyopathy in primary aldosteronism: A state-of-the-art of mechanistic insights, therapeutic strategies, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}